BlackRock’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $63.7K | Buy |
|
|||||
|
2024
Q3 | $562K | Buy |
|
|||||
|
2024
Q2 | $1.34M | Buy |
|
|||||
|
2024
Q1 | $1.38M | Buy |
|
|||||
|
2023
Q4 | $1.92M | Buy |
|
|||||
|
2023
Q3 | $971K | Buy |
|
|||||
|
2023
Q2 | $665K | Buy |
|
|||||
|
2023
Q1 | $502K | Sell |
|
|||||
|
2022
Q4 | $746K | Sell |
|
|||||
|
2022
Q3 | $1.58M | Buy |
|
|||||
|
2022
Q2 | $1.47M | Sell |
|
|||||
|
2022
Q1 | $4.96M | Sell |
|
|||||
|
2021
Q4 | $13.8M | Sell |
|
|||||
|
2021
Q3 | $19.5M | Sell |
|
|||||
|
2021
Q2 | $24.3M | Buy |
|
|||||
|
2021
Q1 | $31.2M | Buy |
|
|||||
|
2020
Q4 | $36.1M | Buy |
|
|||||
|
2020
Q3 | $29.3M | Sell |
|
|||||
|
2020
Q2 | $35.4M | Buy |
|
|||||
|
2020
Q1 | $16.7M | Sell |
|
|||||
|
2019
Q4 | $19.8M | Buy |
|
|||||
|
2019
Q3 | $28.5M | Buy |
|
|||||
|
2019
Q2 | $24.7M | Buy |
|
|||||
|
2019
Q1 | $18.4M | Buy |
|
|||||
|
2018
Q4 | $11.1M | Buy |
|
|||||
|
2018
Q3 | $19.2M | Buy |
|
|||||
|
2018
Q2 | $16.2M | Buy |
|
|||||
|
2018
Q1 | $12.1M | Buy |
|
|||||
|
2017
Q4 | $5.59M | Buy |
|
|||||
|
2017
Q3 | $8.39M | Buy |
|
|||||
|
2017
Q2 | $8.76M | Buy |
|
|||||
|
2017
Q1 | $2.86M | Buy |
|
|||||
|
2016
Q4 | $3K | Buy |
|